120 related articles for article (PubMed ID: 14587029)
1. Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappabeta.
Chen F; Wang M; O'Connor JP; He M; Tripathi T; Harrison LE
J Cell Biochem; 2003 Nov; 90(4):732-44. PubMed ID: 14587029
[TBL] [Abstract][Full Text] [Related]
2. Ciglitazone induces early cellular proliferation and NF-kappaB transcriptional activity in colon cancer cells through p65 phosphorylation.
Chen F; Harrison LE
Int J Biochem Cell Biol; 2005 Mar; 37(3):645-54. PubMed ID: 15618021
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells.
Sung CK; She H; Xiong S; Tsukamoto H
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G722-9. PubMed ID: 14656714
[TBL] [Abstract][Full Text] [Related]
4. The hinge-helix 1 region of peroxisome proliferator-activated receptor gamma1 (PPARgamma1) mediates interaction with extracellular signal-regulated kinase 5 and PPARgamma1 transcriptional activation: involvement in flow-induced PPARgamma activation in endothelial cells.
Akaike M; Che W; Marmarosh NL; Ohta S; Osawa M; Ding B; Berk BC; Yan C; Abe J
Mol Cell Biol; 2004 Oct; 24(19):8691-704. PubMed ID: 15367687
[TBL] [Abstract][Full Text] [Related]
5. 15-lipoxygenase-1 exerts its tumor suppressive role by inhibiting nuclear factor-kappa B via activation of PPAR gamma.
Cimen I; Astarci E; Banerjee S
J Cell Biochem; 2011 Sep; 112(9):2490-501. PubMed ID: 21544861
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancer.
Chen GG; Lee JF; Wang SH; Chan UP; Ip PC; Lau WY
Life Sci; 2002 Apr; 70(22):2631-46. PubMed ID: 12269390
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
Han S; Sidell N; Fisher PB; Roman J
Clin Cancer Res; 2004 Mar; 10(6):1911-9. PubMed ID: 15041706
[TBL] [Abstract][Full Text] [Related]
9. Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappaB activation and transformation in resistant JB6 cells.
Hu J; Nakano H; Sakurai H; Colburn NH
Carcinogenesis; 2004 Oct; 25(10):1991-2003. PubMed ID: 15192014
[TBL] [Abstract][Full Text] [Related]
10. The role of mitogen-activated protein kinases and their relationship with NF-kappaB and PPARgamma in indomethacin-Induced apoptosis of colon cancer cells.
Kim TI; Jin SH; Kang EH; Shin SK; Choi KY; Kim WH
Ann N Y Acad Sci; 2002 Nov; 973():241-5. PubMed ID: 12485869
[TBL] [Abstract][Full Text] [Related]
11. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma-mediated NF-kappa B activation and apoptosis in pre-B cells.
Schlezinger JJ; Jensen BA; Mann KK; Ryu HY; Sherr DH
J Immunol; 2002 Dec; 169(12):6831-41. PubMed ID: 12471115
[TBL] [Abstract][Full Text] [Related]
13. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
14. Induction of plasminogen activator inhibitor I by the PPARalpha ligand, Wy-14,643, is dependent on ERK1/2 signaling pathway.
Banfi C; Auwerx J; Poma F; Tremoli E; Mussoni L
Thromb Haemost; 2003 Oct; 90(4):611-9. PubMed ID: 14515181
[TBL] [Abstract][Full Text] [Related]
15. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
Manna SK; Mukhopadhyay A; Van NT; Aggarwal BB
J Immunol; 1999 Dec; 163(12):6800-9. PubMed ID: 10586080
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
Kaplan J; Cook JA; O'Connor M; Zingarelli B
Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
[TBL] [Abstract][Full Text] [Related]
17. p38 mitogen-activated protein kinase controls NF-kappaB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens.
Olson CM; Hedrick MN; Izadi H; Bates TC; Olivera ER; Anguita J
Infect Immun; 2007 Jan; 75(1):270-7. PubMed ID: 17074860
[TBL] [Abstract][Full Text] [Related]
18. Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
Mol Carcinog; 2002 Nov; 35(3):127-37. PubMed ID: 12410564
[TBL] [Abstract][Full Text] [Related]
19. Activation of phosphatidylinositol 3-kinase and c-Jun-N-terminal kinase cascades enhances NF-kappaB-dependent gene transcription in BCG-stimulated macrophages through promotion of p65/p300 binding.
Darieva Z; Lasunskaia EB; Campos MN; Kipnis TL; Da Silva WD
J Leukoc Biol; 2004 Apr; 75(4):689-97. PubMed ID: 14742634
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone inhibits apoptosis in human colonic cancer cell lines: antagonistic effects of peroxisome proliferator activated receptor-gamma ligands.
Bogazzi F; Ultimieri F; Raggi F; Russo D; Vanacore R; Guida C; Brogioni S; Cosci C; Gasperi M; Bartalena L; Martino E
Endocrinology; 2004 Jul; 145(7):3353-62. PubMed ID: 15070854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
